Mengting Li
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Oncology
- Immunology
- Topics
- Ferroptosis and cancer prognosis (13 papers)Cancer Immunotherapy and Biomarkers (7 papers)RNA modifications and cancer (5 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Mengting Li
30 papers receiving 553 citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Molecular Biology 294
- Pulmonary and Respiratory Medicine 270
- Cancer Research 214
- Oncology 96
- Immunology 61
Countries citing papers authored by Mengting Li
This map shows the geographic impact of Mengting Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengting Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengting Li more than expected).
Fields of papers citing papers by Mengting Li
This network shows the impact of papers produced by Mengting Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengting Li. The network helps show where Mengting Li may publish in the future.
Co-authorship network of co-authors of Mengting Li
This figure shows the co-authorship network connecting the top 25 collaborators of Mengting Li. A scholar is included among the top collaborators of Mengting Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengting Li. Mengting Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 16 | |
| 4 | 6 | |
| 5 | 8 | |
| 6 | 0 | |
| 7 | 16 | |
| 8 | 8 | |
| 9 | 3 | |
| 10 | 6 | |
| 11 | 2 | |
| 12 | 16 | |
| 13 | 7 | |
| 14 | 2 | |
| 15 | 8 | |
| 16 | 66 | |
| 17 | 9 | |
| 18 | 24 | |
| 19 | 8 | |
| 20 | 0 |
About Mengting Li
Mengting Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 35 papers that have together received 559 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (13 papers), Cancer Immunotherapy and Biomarkers (7 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Cancer Research (214 citations), Pulmonary and Respiratory Medicine (270 citations) and Molecular Biology (294 citations). Mengting Li has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Wenjie Li, Qiu Zhao, Yuanyuan Lu, Yanan Peng, Lan Liu, Wanhui Wei, Qian Hu, Cheng Peng, Lan Liu and Jingwen Yin. Their work appears in journals such as Chemical Engineering Journal, Journal of Medicinal Chemistry and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.